On Cancer

Filter by Tag

Video

By Memorial Sloan-Kettering | Wednesday, April 10, 2013

Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.

Tags: Cancer Care; Treatment; Leukemias; Research

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens

In the Clinic

Cell-Based Immune Therapy Shows Promise in Leukemia Patients

By Jim Stallard, MA, Writer/Editor | Wednesday, March 20, 2013

Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

Tags: Cancer Care; Clinical Trials; Cell Engineering; Experimental Therapeutics; Leukemias; Research

Video

Meet Leukemia Expert Stephen Chung

By Memorial Sloan-Kettering | Monday, March 18, 2013

Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care.

Tags: Cancer Care; Treatment; Leukemias

In the Lab

New Molecule Targets Proteins Inside Cancer Cells

By Julie Grisham, MS, Science Writer/Editor | Wednesday, March 13, 2013

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Tags: Targeted Therapy; Molecular Pharmacology; Leukemias; Research

Video

Meet Leukemia Expert Martin Tallman

By Memorial Sloan-Kettering | Wednesday, February 27, 2013

Chief of the Leukemia Service Dr. Tallman discusses how experts collaborate to deliver the most-promising therapies, and how he cares for patients as if they were members of his own family.

Tags: Cancer Care; Treatment; Leukemias

Honor

Physician-Scientist Charles Sawyers Awarded Breakthrough Prize in Life Sciences

By Media Staff | Wednesday, February 20, 2013

Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

Tags: Drug Discovery; Targeted Therapy; Treatment; Leukemias; Prostate Cancer; Research

Feature

Cancer Genomics: Improved Understanding of Molecular Changes in Tumors Produces More-Specialized Treatments

By Jim Stallard, MA and Julie Grisham, MS
Friday, September 21, 2012

With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.

Tags: Cancer Genetics; Acute Myelogenous Leukemia; Colorectal Cancer; Leukemias; Lung Cancer; Melanoma; Pancreatic Cancer; Soft Tissue Sarcoma; Stomach (Gastric) Cancer; Research

In the Lab

Researchers Discover Why Some Leukemia Drugs Are Not Sufficiently Effective

By Jim Stallard, MA, Writer/Editor | Thursday, September 6, 2012

Memorial Sloan-Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.

Tags: Cancer Care; Cancer Genetics; Leukemias; Research

Pictured: Natural Killer Cells & Cancer Cell

In the Lab

Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia

By Eva Kiesler, PhD, Science Writer/Editor | Tuesday, September 4, 2012

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.

Tags: Blood & Marrow Stem Cell Transplantation; Cancer Genetics; Immunology; Leukemias; Research

In the Lab

Genetic Profiling Could Help Doctors Make More-Accurate Leukemia Prognoses

By Jim Stallard, MA, Writer/Editor | Thursday, March 15, 2012

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

Tags: Cancer Biology; Cancer Genetics; Acute Myelogenous Leukemia; Pediatric Leukemias; Personalized Medicine; Leukemias; Research

Profile

Genetic Causes of Blood Cancers Explored

By Jim Stallard, MA, Writer/Editor | Tuesday, December 20, 2011

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

Tags: Cancer Biology; Cancer Genetics; Leukemias; Lymphomas; Research